Literature DB >> 3048824

Keloids.

A P Kelly1.   

Abstract

Keloids are benign fibrous growths that result from an abnormal connective tissue response in certain predisposed individuals. Blacks form keloids more often than whites; however, the reason for this racial difference is not known. Trauma, foreign-body reactions, infections, and endocrine dysfunction have all been proposed as precipitating factors. Keloids are found most commonly on the ear lobes, shoulders, upper back, and midchest. They extend past the area of trauma and once present tend to remain stable. Although sometimes pruritic, painful, or tender, they are usually asymptomatic. Histologically, keloids are characterized by thick collagen bundles, abundant mucinous ground substance, few fibroblasts, and few if any foreign-body reactions. Although there have been many therapeutic modalities, most have had limited success. The most commonly used therapeutic approach is a combination of cryotherapy, intralesional steroid injections, surgical excision, and pressure devices.

Entities:  

Mesh:

Year:  1988        PMID: 3048824

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  14 in total

1.  A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population.

Authors:  Mitsuko Nakashima; Suyoun Chung; Atsushi Takahashi; Naoyuki Kamatani; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Naoya Hosono; Michiaki Kubo; Yusuke Nakamura; Hitoshi Zembutsu
Journal:  Nat Genet       Date:  2010-08-15       Impact factor: 38.330

2.  An intra-individual surgical wound comparison shows that octenidine-based hydrogel wound dressing ameliorates scar appearance following abdominoplasty.

Authors:  Johannes Matiasek; Philip Kienzl; Lukas W Unger; Christoph Grill; Rupert Koller; Bela R Turk
Journal:  Int Wound J       Date:  2018-06-29       Impact factor: 3.315

3.  West Indies Glaucoma Laser Study (WIGLS) 3. Anterior Chamber Inflammation Following Selective Laser Trabeculoplasty in Afro-Caribbeans with Open-angle Glaucoma.

Authors:  Tony Realini; Hazel Shillingford-Ricketts; Darra Burt; Goundappa K Balasubramani
Journal:  J Glaucoma       Date:  2019-07       Impact factor: 2.503

4.  Genomic risk variants at 3q22.3 are associated with keloids in a Chinese Han population.

Authors:  Meng-Zhu Lu; Qian-Qian Ang; Xiang Zhang; Lan-Fang Zhang; Xiu-Hua Yao; Hong Lv; Xiao-Dong Zheng; Wen-Sheng Lu
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

5.  Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important?

Authors:  D Broadway; I Grierson; R Hitchings
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

Review 6.  Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Authors:  Tiffany A Wallace; Damali N Martin; Stefan Ambs
Journal:  Carcinogenesis       Date:  2011-04-03       Impact factor: 4.944

Review 7.  Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?

Authors:  Zohreh Tatari-Calderone; Naomi L C Luban; Stanislav Vukmanovic
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

8.  Keloid scarring: understanding the genetic basis, advances, and prospects.

Authors:  Ahmad Sukari Halim; Azadeh Emami; Iman Salahshourifar; Thirumulu Ponnuraj Kannan
Journal:  Arch Plast Surg       Date:  2012-05-10

9.  Description of familial keloids in five pedigrees: evidence for autosomal dominant inheritance and phenotypic heterogeneity.

Authors:  Jason A Clark; Maria L Turner; Lillian Howard; Horia Stanescu; Robert Kleta; Jeffrey B Kopp
Journal:  BMC Dermatol       Date:  2009-07-28

Review 10.  Chronic itch in African Americans: an unmet need.

Authors:  Giuseppe Ingrasci; Nour El-Kashlan; Andrew Alexis; Gil Yosipovitch
Journal:  Arch Dermatol Res       Date:  2021-06-15       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.